Esophageal malignant tumor is one of the common digestive system malignant tumors. It is difficult to detect early, and there are great individual differences. In order to further explore the differences in blood indexes between patients with esophageal malignant tumors and healthy people, this study used the LIS information system to collect a large number of blood test data for statistical analysis. In this study, 346 patients with esophageal malignant tumors who visited a doctor at the same time were selected as the experimental group, and 906 people with physical examination were selected as the control group. The study found that serum albumin, fasting blood glucose, total cholesterol, triglyceride, high-density lipoprotein and other blood test indicators of patients with esophageal malignant tumor were significantly different from those of healthy people. The above blood test indicators can build an early screening model for esophageal malignant tumors. This study uses the medical health data stored in the LIS information system to verify the differences in blood indicators between patients with esophageal malignant tumors and healthy people, and establish a digital model for early screening of patients with esophageal cancer, which is conducive to rapid and accurate early screening of esophageal cancer. Provide reference for early detection and timely treatment of esophageal cancer.
The prevalence of nasopharyngeal carcinoma is the first in otolaryngology head and neck malignancies. The location of the disease is hidden, and most patients are already in the advanced stage of cancer when they are found. In order to explore the construction of an index model of early dyslipidemia in patients with nasopharyngeal carcinoma, this study used the laboratory information management system to obtain a large amount of blood test data and used statistical software to conduct correlation analysis with healthy people. Through the analysis, a dyslipidemia index model belonging to the early screening of nasopharyngeal carcinoma can be gradually constructed. In this study, 55 patients with nasopharyngeal carcinoma who visited a doctor at the same time were selected as the experimental group, and 1244 people with physical examination were selected as the control group. The study found that the serum total cholesterol, triglyceride, and high-density lipoprotein of patients with nasopharyngeal carcinoma were significantly lower than those of healthy people. Serum total cholesterol, triglyceride, and high-density lipoprotein can be used as basic data for early dyslipidemia index model in patients with nasopharyngeal carcinoma. In this study, a screening model of early blood lipid metabolism indicators in nasopharyngeal carcinoma patients was constructed by means of the blood test data stored in the laboratory information management system, which provided a theoretical reference for the early screening of nasopharyngeal carcinoma patients.
Rectal cancer is the most common malignant tumor of the digestive tract, and its incidence ranks third among all types of tumors. To investigate the differences in lipid metabolism between patients with rectal malignancies and healthy individuals, this study used the LIS information system to obtain a large amount of blood test data and used statistical software to perform correlation analysis. The data of the experimental group in this study came from the detection information of 502 patients with rectal cancer extracted by LIS. The data of the control group were obtained from the detection information of 1251 physical examiners. Human lipid metabolism is mainly expressed by indicators such as high-density lipoprotein, triglyceride, total cholesterol, low-density lipoprotein, apolipoprotein AI and apolipoprotein B. This study found that the blood lipid index of healthy people was significantly higher than that of patients with rectal cancer. This study uses the medical information data extracted by LIS as the experimental object. Through comparative analysis, when the human body develops rectal cancer lesions, the lipid metabolism level of the body will decrease significantly. The evaluation of blood lipid metabolism can provide a theoretical reference for improving the quality of life and prognosis of patients with rectal cancer.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.